AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Intro
This chapter explores Medicare's recent announcement of over 200 drugs priced at $2, aimed at assisting seniors and those with high medication costs. It also discusses improvements in prostate cancer screening and the importance of adjusting treatment strategies to prevent overtreatment of less aggressive cases.